首页 > 市场调查报告书 > 医疗设备

生技设备

病毒过滤市场规模、份额及成长分析（按产品、应用、最终用户及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902378

病毒过滤市场规模、份额及成长分析（按产品、应用、最终用户及地区划分）－2026-2033年产业预测

Virus Filtration Market Size, Share, and Growth Analysis, By Product (Kits and Reagents, Filtration Systems), By Application (Biologicals, Medical Devices), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 193 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球病毒过滤市场规模预计在 2024 年达到 58.5 亿美元，从 2025 年的 64.5 亿美元成长到 2033 年的 141.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 10.3%。

全球病毒过滤市场正经历显着成长，这主要得益于生物製药需求的不断增长，而生物製剂需要严格的病毒安全通讯协定。生物製药公司越来越依赖病毒过滤技术来确保单株抗体和重组蛋白等产品的纯度。对病毒去除的重视源于研发投入的增加以及政府旨在加强生物製造能力的扶持措施。关键驱动因素是对技术创新的高度重视。业界领导企业正在投资先进的薄膜技术，例如奈米纤维和一次性过滤系统，以提高处理量并最大限度地减少污染。该市场的应用范围也已从传统的生物製药扩展到医疗设备、水处理和空气净化等领域。此外，自动化和策略伙伴关係正在促进客製化解决方案的快速应用和联合开发。

全球病毒过滤市场驱动因素

全球病毒过滤市场正经历显着成长，这主要得益于人们对生物製药疗法和mRNA疫苗的日益关注，而有效的病毒安全措施对于这些疗法至关重要。随着生物製药和生物製造公司致力于开发包括单株抗体、重组蛋白和基因疗法在内的创新治疗方法，在生产的每个阶段，可靠病毒过滤的需求都至关重要。对病毒安全性的日益重视，加上不断扩展的生物製药产品线，促使製造商投资先进的病毒去除过滤器，以满足严格的纯度标准。因此，随着全球生物生产的扩张，病毒过滤系统市场也蓬勃发展。

限制全球病毒过滤市场的因素

全球病毒过滤市场面临许多限制因素，例如一次性系统和奈米纤维膜等新兴病毒过滤技术初期投入成本高。中小型生物製药公司往往难以拨出足够的预算来购买昂贵的设备和客製化耗材，以及聘请操作这些系统所需的专业人员。此外，定期更换滤芯和验证流程等持续性支出也加重了企业的财务负担。这些成本迭加起来，可能会阻碍企业（尤其是在发展中市场）投资和采用新技术，从而限制其获得先进的过滤过滤解决方案。

全球病毒过滤市场趋势

全球病毒过滤市场正经历着向一次性使用和连续生物工艺平台的显着转变。製造商越来越多地采用一次性系统，这不仅降低了交叉污染的风险，还消除了与清洁和验证相关的停机时间，从而带来显着优势，尤其是在多产品生产设施中。此外，连续生物製程透过不间断地去除病毒来提高生产效率，在保持严格的病毒安全措施的同时优化了生产通量。这种模组化、一次性设备的趋势符合产业对柔软性的需求，能够快速部署和重新配置以适应产能变化，最终缩短生物製药产品的上市时间。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Merck KGaA
Danaher
Sartorius AG
Thermo Fisher Scientific Inc.
GE HealthCare
Charles River Laboratories
Asahi Kasei Medical Co., Ltd.
Sartorius AG
Lonza
Sigma-Aldrich Corporation
Clean Biologics

结论与建议

简介目录

Product Code: SQMIG35A3058

Global Virus Filtration Market size was valued at USD 5.85 Billion in 2024 and is poised to grow from USD 6.45 Billion in 2025 to USD 14.13 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The global virus filtration market is experiencing significant growth, fueled by the rising demand for biologics that require stringent viral safety protocols. Biopharmaceutical companies increasingly rely on virus filtration to guarantee the purity of products like monoclonal antibodies and recombinant proteins. The focus on viral clearance is bolstered by heightened R&D investments and supportive government initiatives aimed at enhancing biomanufacturing capabilities. Key drivers include a strong emphasis on technological innovation, with industry leaders investing in advanced membrane technologies, such as nanofiber and single-use filter systems, to improve throughput and minimize contamination. The market is also expanding beyond traditional biologics to include applications in medical devices, water treatment, and air purification, while automation and strategic partnerships are facilitating faster adoption and co-development of tailored solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virus Filtration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Virus Filtration Market Segments Analysis

Global Virus Filtration Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Kits and Reagents, Filtration Systems, Services and Other Products. Based on Application, the market is segmented into Biologicals, Medical Devices, Water Purification and Air Purification. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Medical Device Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Virus Filtration Market

The global virus filtration market is experiencing significant growth, driven by the increasing focus on biologic therapies and mRNA-based vaccines that necessitate effective viral safety measures. As biopharmaceutical and biomanufacturing companies strive to develop innovative therapies, including monoclonal antibodies, recombinant proteins, and gene therapies, the demand for reliable virus filtration becomes crucial at every stage of production. This heightened emphasis on viral safety, alongside the expansion of biologics pipelines, compels manufacturers to invest in advanced virus-removal filters to meet rigorous purity standards. Consequently, the market for virus filtration systems is thriving as biological production continues to grow worldwide.

Restraints in the Global Virus Filtration Market

The Global Virus Filtration market faces significant restraints due to the high initial capital costs associated with emerging virus filtration technologies, such as single-use systems and nanofiber membranes. Smaller and mid-sized biopharma companies often struggle to allocate sufficient budgets for costly capital equipment and custom consumables, as well as for the trained personnel required to operate these systems. Furthermore, the ongoing expenses related to routine filter replacements and the validation process add to the financial burden. These combined costs may lead companies, especially in developing markets, to hesitate in investing in and adopting newer technologies, limiting their access to advanced sterilization filtration solutions.

Market Trends of the Global Virus Filtration Market

The Global Virus Filtration market is witnessing a significant shift towards single-use and continuous bioprocessing platforms. Manufacturers are increasingly adopting single-use systems, which not only mitigate the risk of cross-contamination but also reduce downtime associated with cleaning and validation, making them especially advantageous for multiproduct facilities. Additionally, continuous bioprocessing enhances productivity by ensuring uninterrupted viral clearance, which optimizes throughput while maintaining robust viral safety measures. This trend towards modular, disposable units aligns with industry demands for flexibility, allowing for rapid deployment and reconfiguration to adapt to varying production capabilities, ultimately accelerating time-to-market for biopharmaceuticals.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Virus Filtration Market Size by Product & CAGR (2026-2033)

Market Overview
Kits and Reagents
Filtration Systems
Services
Other Products

Global Virus Filtration Market Size by Application & CAGR (2026-2033)

Market Overview
Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Stem Cell Products
Medical Devices
Water Purification
Air Purification

Global Virus Filtration Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Medical Device Companies

Global Virus Filtration Market Size & CAGR (2026-2033)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE HealthCare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Medical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clean Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments